文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

疟原虫驱动的免疫调节网络对疟疾免疫的影响。

The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.

机构信息

Life Sciences Division, Burnet Institute, Melbourne, Victoria, Australia.

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

出版信息

Nat Rev Immunol. 2024 Sep;24(9):637-653. doi: 10.1038/s41577-024-01041-5. Epub 2024 Jun 11.


DOI:10.1038/s41577-024-01041-5
PMID:38862638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11688169/
Abstract

Malaria, caused by infection with Plasmodium parasites, drives multiple regulatory responses across the immune landscape. These regulatory responses help to protect against inflammatory disease but may in some situations hamper the acquisition of adaptive immune responses that clear parasites. In addition, the regulatory responses that occur during Plasmodium infection may negatively affect malaria vaccine efficacy in the most at-risk populations. Here, we discuss the specific cellular mechanisms of immunoregulatory networks that develop during malaria, with a focus on knowledge gained from human studies and studies that involve the main malaria parasite to affect humans, Plasmodium falciparum. Leveraging this knowledge may lead to the development of new therapeutic approaches to increase protective immunity to malaria during infection or after vaccination.

摘要

疟疾是由疟原虫感染引起的,它会在整个免疫领域引发多种调节反应。这些调节反应有助于预防炎症性疾病,但在某些情况下,可能会阻碍清除寄生虫的适应性免疫反应的产生。此外,疟疾感染期间发生的调节反应可能会对高危人群的疟疾疫苗效力产生负面影响。在这里,我们讨论了疟疾期间形成的免疫调节网络的特定细胞机制,重点介绍了从人类研究和涉及主要疟原虫(对人类有影响的疟原虫)的研究中获得的知识。利用这些知识可能会开发出新的治疗方法,以在感染期间或接种疫苗后增加对疟疾的保护性免疫。

相似文献

[1]
The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria.

Nat Rev Immunol. 2024-9

[2]
The Impact of Established Immunoregulatory Networks on Vaccine Efficacy and the Development of Immunity to Malaria.

J Immunol. 2016-12-15

[3]
Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it.

Immunol Rev. 2019-9-27

[4]
Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.

Front Immunol. 2018-12-19

[5]
Metabolome modulation of the host adaptive immunity in human malaria.

Nat Metab. 2021-7

[6]
Inducible mechanisms of disease tolerance provide an alternative strategy of acquired immunity to malaria.

Elife. 2021-3-23

[7]
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Immunol Rev. 2019-12-16

[8]
The march toward malaria vaccines.

Vaccine. 2015-11-27

[9]
The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.

Curr Opin Infect Dis. 2013-10

[10]
Complement in malaria immunity and vaccines.

Immunol Rev. 2019-9-26

引用本文的文献

[1]
Plasmodium falciparum egress disrupts endothelial junctions and activates JAK-STAT signaling in a microvascular 3D blood-brain barrier model.

Nat Commun. 2025-8-6

[2]
Bifunctional chemokine-nanobody fusion protein enhances neutrophil recruitment to impede Acanthamoeba immune evasion.

EBioMedicine. 2025-5

[3]
Black Phosphorous-Based Surface Plasmon Resonance Biosensor for Malaria Diagnosis.

Sensors (Basel). 2025-3-26

[4]
Single-cell transcriptomics reveals inter-ethnic variation in immune response to Falciparum malaria.

Am J Hum Genet. 2025-3-6

[5]
Malaria: Factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy.

PLoS Pathog. 2025-1-23

[6]
Laboratory detection of donors implicated in transfusion-transmitted malaria.

Transfusion. 2024-12

本文引用的文献

[1]
Entire expressed peripheral blood transcriptome in pediatric severe malarial anemia.

Nat Commun. 2024-6-12

[2]
Systemic inflammatory response syndrome triggered by blood-borne pathogens induces prolonged dendritic cell paralysis and immunosuppression.

Cell Rep. 2024-2-27

[3]
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.

Lancet. 2024-2-10

[4]
Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets.

Nat Commun. 2023-11-15

[5]
Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria.

BMC Infect Dis. 2023-10-23

[6]
Mechanistic insights into the interaction between the host gut microbiome and malaria.

PLoS Pathog. 2023-10

[7]
STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria.

J Clin Invest. 2023-10-2

[8]
Immunological factors linked to geographical variation in vaccine responses.

Nat Rev Immunol. 2024-4

[9]
Malaria-specific Type 1 regulatory T cells are more abundant in first pregnancies and associated with placental malaria.

EBioMedicine. 2023-9

[10]
A systematic analysis of the human immune response to Plasmodium vivax.

J Clin Invest. 2023-10-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索